A carregar...
Understanding patients’ perspective of statin therapy: can we design a better approach to the management of dyslipidaemia? A literature review
INTRODUCTION: Dyslipidaemia leads to atherosclerosis and is a major risk factor for cardiovascular diseases. In clinical trials, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, or statins, have been shown to effectively reduce dyslipidaemia. Despite the availability and accessi...
Na minha lista:
| Publicado no: | Singapore Med J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Singapore Medical Association
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4294090/ https://ncbi.nlm.nih.gov/pubmed/25189302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11622/smedj.2014099 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|